Updated clinical and economic analysis of using follitropin alfa in combination with assisted reproductive technologies in 2022

Objective: to perform a clinical and economic analysis of using drugs containing follitropin alfa as an active substance and to assess the impact of the studied drugs on the budget of the state healthcare system of the Russian Federation considering cost data for 2022 in the population of women with...

Full description

Saved in:
Bibliographic Details
Main Authors: D. G. Shchurov, D. V. Blinov, N. V. Bashmakova, M. A. Polzikov, A. S. Semikhin
Format: Article
Language:Russian
Published: IRBIS LLC 2023-04-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/796
Tags: Add Tag
No Tags, Be the first to tag this record!